menu
    • menu

    Company profile for WEX Pharmaceuticals

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    WEX Pharmaceuticals Inc. (“WEX” or the “Company”) is a private biopharmaceutical company based in Vancouver, Canada, developing a new class of non-opioid analgesics. WEX’s proprietary platform and the lead product is Halneuron®. The active pharmaceutical ingredient in Halneuron is Tetrodotoxin (“TTX”) which is a proven sodium channel blocker.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    WEX PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 1150 – 1100 Melville Street Vancouver, BC
    Telephone
    Telephone
    604-683-8880
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://wexpharma.com/about-us/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dogwood Therapeutics Announces Q3 2024 Financial Results
    Dogwood Therapeutics Announces Q3 2024 Financial Results

    07 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/07/2976537/0/en/Dogwood-Therapeutics-Announces-Third-Quarter-2024-Financial-Results.html

    GLOBENEWSWIRE
    07 Nov 2024
    Share Share
    Virios And Wex Announce Merger To Form Dogwood Therapeutics
    Virios And Wex Announce Merger To Form Dogwood Therapeutics

    07 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/07/2958810/0/en/Virios-Therapeutics-Inc-and-Wex-Pharmaceuticals-Inc-Announce-Business-Combination-to-Form-Dogwood-Therapeutics-Inc-Nasdaq-DWTX.html

    GLOBENEWSWIRE
    07 Oct 2024
    Share Share
    Wex Pharmaceuticals Inc. Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers’ Sensory Perceptions
    Wex Pharmaceuticals Inc. Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers’ Sensory Perceptions

    11 Dec 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=814693&lang=en

    ACCESSWIRE
    11 Dec 2023
    Share Share
    Wex Pharma Enrolls the First Patient Ph 2b Trial Evaluating the Efficacy& Safety
    Wex Pharma Enrolls the First Patient Ph 2b Trial Evaluating the Efficacy& Safety

    03 Jan 2023

    // ACCESSWIRE

    https://www.accesswire.com/733722/Wex-Pharmaceuticals-Inc-Enrolls-the-First-Patient-in-The-Phase-2b-Clinical-Trial-Evaluating-the-Efficacy-and-Safety-of-HalneuronR-In-the-Treatment-of-Chemotherapy-Induced-Neuropathic-Pain

    ACCESSWIRE
    03 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Contact WEX Pharmaceuticals and get a quotation

    WEX Pharmaceuticals is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Tetrodotoxin bulk offered by WEX Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search